Navigation Links
Nuvasive Reports Third Quarter 2008 Financial Results
Date:10/22/2008

culates the non-GAAP financial measures provided in this earnings release excluding these costs and uses these non-GAAP financial measures to enable it to analyze further and more consistently the period-to-period financial performance of its core business operations. Management believes that providing investors with these non-GAAP measures gives them additional important information to enable them to assess, in the same way management assesses, the Company's current and future continuing operations. These non-GAAP measures are not in accordance with, or an alternative for, GAAP, and may be different from non-GAAP measures used by other companies. Set forth below are reconciliations of the non-GAAP financial measures to the comparable GAAP financial measure.

Reconciliation of Third Quarter 2008 Results

(in thousands, except per share amounts) $ Per Share

GAAP net loss per share (A) $(23,079) $(0.64)

In-process research and development (IPR&D) (C) 16,700 0.46

Other adjustments (E) 7,991 0.22

Earnings per share excluding IPR&D and other

adjustments 1,612 0.04

Stock-based compensation (B) 5,421 0.14

Amortization of acquired intangible assets (D) 931 0.03

Non-GAAP earnings per share (A) $7,964 $0.21

Shares used in computing GAAP net loss per

share (A) 35,931

Shares used in computing non-GAAP net loss per

share (A) 37,927

Reconciliation of Full Year 2008 Guidance

Range for Year Ending

(in thousands, except per share amounts) December 31, 2008'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. NuVasive to Present at Morgan Stanley Global Healthcare Unplugged Conference
2. NuVasive Completes Acquisition of Osteocel Biologics Business
3. NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results
4. NuVasive to Present at William Blair 28th Annual Growth Stock Conference
5. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
6. NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference
7. NuVasive to Present at Canaccord Adams Small-Cap Orthopedics Conference
8. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
9. NuVasive to Host Investor Reception on September 11, 2007
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, ... exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, ... the Russian Federation , ... Independent States (CIS). Nemonoxacin is a novel antibiotic for the ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Carahsoft and ... Thursday, January 23, 2014 at 2pm EST (11am PST), ... The topic focuses on how technology can turn raw, ... decisions for government agencies. The online webinar will last ...
(Date:1/14/2014)... leading provider of strategic communications services to corporations and organizations preparing ... the United States and Europe , ... returning to the firm,s Washington, D.C. office. ... two years of service as Associate Commissioner for the Office of ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... not your parents' generation of corporate leaders. , ,A ... cross the lips of gray-haired, gray-suited corporate executives. Today, ... Wisconsin doesn't yet have it. , ,At the Olympia ... academic and arts groups met to brainstorm strategies for ...
... Wis. - The 53 Wisconsin companies that won ... Innovation Research (SBIR) and Small Business Technology Transfer (STTR) ... at an upcoming banquet in Madison. , ,The awards ... transfer workshop. The workshop will focus on SBIR/STTR funding ...
... 30 years ago, then-Gov. Pat Lucey and the Wisconsin ... property taxes. It was a bipartisan decision that has ... times and foreign competition threatened. , ,Today, Wisconsin policymakers ... a competitive toehold by reducing state taxes that discourage ...
Cached Biology Technology:Tech leaders call for more creativity 2Modernizing the tax code can make Wisconsin tech businesses more competitive 2Modernizing the tax code can make Wisconsin tech businesses more competitive 3
(Date:4/24/2014)... turtle in North America, weighing in at up to ... from Florida and the University of Vermont have discovered ... , Examining museum specimens and wild turtles, the scientists ... Once heavily hunted for turtle meat alligator snapper ... the 1960s the riverine populations have been deeply ...
(Date:4/23/2014)... and other chronic inflammatory disorders among people of lower ... reduced exposure to the microbes that thrive in rural ... article, published in the journal Clinical & Experimental ... who have less access to green spaces may be ... by immune system dysfunction. , When our immune systems ...
(Date:4/23/2014)... in their mid-thirties and forties, face a devastating ... two decades. "Mutant" protein clusters, long blamed for ... the primary focus of therapies in development by ... Prof. Gerardo Lederkremer and Dr. Julia Leitman of ... Immunology, in collaboration with Prof. Ulrich Hartl of ...
Breaking Biology News(10 mins):Two new US turtle species described 2Two new US turtle species described 3Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3On the defensive 2On the defensive 3
... some have argued, can be reversed with a large-scale ... liquefied sulfur dioxide in the stratosphere or building tens ... to filter out carbon dioxide. ... of Atmospheric and Oceanic Sciences and a member and ...
... biological tit for tat may hold clues to improving ... type 1 diabetes, according to a Medical College of ... attacks insulin-producing cells causing high blood glucose levels that ... an immunologist in the MCG Center for Biotechnology and ...
... Ind. - Purdue University researchers found a mechanism that ... how to keep that switch turned on may be ... Nicholas Carpita, a professor of botany and plant pathology, ... in plant development by shutting off genes involved in ...
Cached Biology News:No quick or easy technological fix for climate change, researchers say 2No quick or easy technological fix for climate change, researchers say 3No quick or easy technological fix for climate change, researchers say 4High blood sugar's impact on immune system holds clues to improving islet cell transplants 2High blood sugar's impact on immune system holds clues to improving islet cell transplants 3Researchers find nature's shut-off switch for cellulose production 2
Porcine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11...
Recombinant Viral CCI/Fc Chimera, CF...
... • Guinea Pig serum is collected from fasted ... N-02: Citrate N-04: Heparin (Na) ... Oxalate N-10: EDTA (Na) N-03: ... CPD N-09: K3EDTA N-11: ...
GENOMIPHI V2 DNA AMP KIT 25RXN, 1 EA. Category: Genomics DNA Amplification....
Biology Products: